Published in Nat Rev Endocrinol on May 10, 2011
A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants. Eur J Endocrinol (2013) 0.99
Mechanism of thyrotoxic periodic paralysis. J Am Soc Nephrol (2012) 0.89
Thyrotoxic periodic paralysis associated with transient thyrotoxicosis due to painless thyroiditis. J Korean Med Sci (2012) 0.81
Thyrotoxic Periodic Paralysis and Polymorphisms of the ADRB2, AR, and GABRA3 Genes in Men with Graves Disease. Endocrinol Metab (Seoul) (2016) 0.76
A 20-year-old Chinese man with recurrent hypokalemic periodic paralysis and delayed diagnosis. BMJ Case Rep (2012) 0.75
Periodic Paralysis as a New Phenotype of Resistance to Thyroid Hormone Syndrome in a Chinese Male Adult. J Clin Endocrinol Metab (2015) 0.75
An unusual cause of muscle weakness: a diagnostic challenge for clinicians. BMJ Case Rep (2012) 0.75
Whole genome and exome sequencing realignment supports the assignment of KCNJ12, KCNJ17, and KCNJ18 paralogous genes in thyrotoxic periodic paralysis locus: functional characterization of two polymorphic Kir2.6 isoforms. Mol Genet Genomics (2016) 0.75
Optimizing nucleic acid extraction from thyroid fine-needle aspiration cells in stained slides, formalin-fixed/paraffin-embedded tissues, and long-term stored blood samples. Arq Bras Endocrinol Metabol (2012) 2.57
Early diagnosis of multiple endocrine neoplasia type 2B: a challenge for physicians. Arq Bras Endocrinol Metabol (2008) 0.93
Three years follow-up of pamidronate therapy in two brothers with osteoporosis-pseudoglioma syndrome (OPPG) carrying an LRP5 mutation. J Pediatr Endocrinol Metab (2008) 0.86
Oncogenic osteomalacia: loss of hypophosphatemia might be the key to avoid misdiagnosis. Arq Bras Endocrinol Metabol (2012) 0.83
Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone. Endocr Pract (2013) 0.83
Measurement of calcitonin and calcitonin gene-related peptide mRNA refines the management of patients with medullary thyroid cancer and may replace calcitonin-stimulation tests. Thyroid (2013) 0.80
Ion channelopathies in endocrinology: recent genetic findings and pathophysiological insights. Arq Bras Endocrinol Metabol (2010) 0.80
Murine retroviruses re-engineered for lineage tracing and expression of toxic genes in the developing chick embryo. Dev Dyn (2008) 0.80
A ten-year clinical update of a large RET p.Gly533Cys kindred with medullary thyroid carcinoma emphasizes the need for an individualized assessment of affected relatives. Clin Endocrinol (Oxf) (2013) 0.77
Familial combined pituitary hormone deficiency due to a novel mutation R99Q in the hot spot region of Prophet of Pit-1 presenting as constitutional growth delay. J Clin Endocrinol Metab (2003) 0.77
Perspectives in isolation of microRNA from thyroid fine-needle aspiration: reply to the letter "Nucleic acid recovery from thyroid fine-needle cytology slides". Arq Bras Endocrinol Metabol (2013) 0.75
Perspectives in isolation of microRNA from thyroid fine-needle aspiration: reply to the letter "Nucleic acid recovery from thyroid fine-needle cytology slides". Arq Bras Endocrinol Metabol (2013) 0.75
Getting your report seen in and beyond ABE&M. Arq Bras Endocrinol Metabol (2008) 0.75
THE COMBINED USE OF CALCITONIN DOUBLING TIME AND (18)F-FDG PET/CT IMPROVES PROGNOSTIC VALUES IN MEDULLARY THYROID CARCINOMA: THE CLINICAL UTILITY OF (18)F-FDG PET/CT. Endocr Pract (2017) 0.75